Management and Long-Term Outcomes of Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS) in Children: A Scoping Review
Authors (first, second and last of 8)
Collection
Pediatric Dermatology
A collection of recent reviews and original research articles on issues in the management of dermatological conditions in pediatric patients, published in Pediatric Drugs or the American Journal of Clinical Dermatology
Articles (56 in this collection)
-
-
Dupilumab Safety and Efficacy up to 1 Year in Children Aged 6 Months to 5 Years with Atopic Dermatitis: Results from a Phase 3 Open-Label Extension Study
Authors (first, second and last of 10)
-
Efficacy, Safety, and Long-Term Disease Control of Ruxolitinib Cream Among Adolescents with Atopic Dermatitis: Pooled Results from Two Randomized Phase 3 Studies
Authors (first, second and last of 13)
-
Treatment Options for Alopecia Areata in Children and Adolescents
Authors (first, second and last of 4)
-
Infections in Children Aged 6 Months to 5 Years Treated with Dupilumab in a Placebo-Controlled Clinical Trial of Moderate-to-Severe Atopic Dermatitis
Authors (first, second and last of 10)
-
Topical Management of Pediatric Psoriasis: A Review of New Developments and Existing Therapies
Authors (first, second and last of 4)
-
Hidradenitis Suppurativa in Children and Adolescents: An Update on Pharmacologic Treatment Options
Authors (first, second and last of 4)
-
Secukinumab in Pediatric Patients with Plaque Psoriasis: Pooled Safety Analysis from Two Phase 3 Randomized Clinical Trials
Authors (first, second and last of 13)
-
-
Dupilumab Provides Clinically Meaningful Responses in Children Aged 6–11 Years with Severe Atopic Dermatitis: Post Hoc Analysis Results from a Phase III Trial
Authors (first, second and last of 9)
-
Diagnosis and Management of Pediatric Chronic Hand Eczema: The PeDRA CACHES Survey
Authors (first, second and last of 8)
-
Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: An Integrated Analysis of Eight Clinical Trials
Authors (first, second and last of 14)
-
Once-Daily Crisaborole Ointment, 2%, as a Long-Term Maintenance Treatment in Patients Aged ≥ 3 Months with Mild-to-Moderate Atopic Dermatitis: A 52-Week Clinical Study
Authors (first, second and last of 11)
-
-
Truncal Acne and Scarring: A Comprehensive Review of Current Medical and Cosmetic Approaches to Treatment and Patient Management
Authors (first, second and last of 6)
-
Laboratory Safety from a Randomized 16-Week Phase III Study of Dupilumab in Children Aged 6 Months to 5 Years with Moderate-to-Severe Atopic Dermatitis
Authors (first, second and last of 11)
-
-
-
Dupilumab Treatment in Children Aged 6–11 Years With Atopic Dermatitis: A Multicentre, Real-Life Study
Authors (first, second and last of 38)
-
-
Recent Developments and Advances in Atopic Dermatitis: A Focus on Epidemiology, Pathophysiology, and Treatment in the Pediatric Setting
Authors (first, second and last of 6)
-
Efficacy of Secukinumab Across Subgroups and Overall Safety in Pediatric Patients with Moderate to Severe Plaque Psoriasis: Week 52 Results from a Phase III Randomized Study
Authors (first, second and last of 11)
-
-
Long-Term Efficacy and Safety of Dupilumab in Adolescents with Moderate-to-Severe Atopic Dermatitis: Results Through Week 52 from a Phase III Open-Label Extension Trial (LIBERTY AD PED-OLE)
Authors (first, second and last of 16)
-
Effectiveness and Safety of Adalimumab, Etanercept and Ustekinumab for Severe Psoriasis in Children Under 12 Years of Age: A French-Italian Daily Practice Cohort (BiPe Jr)
Authors (first, second and last of 22)
-
Subgroup Analysis of Crisaborole for Mild-to-Moderate Atopic Dermatitis in Children Aged 2 to < 18 Years
Authors (first, second and last of 7)
-
Early Treatment Initiation Improves Outcomes in Nevus of Ota: A 10-Year Retrospective Study
Authors (first, second and last of 4)
-
-
-
Laboratory Safety of Dupilumab in Patients Aged 6–11 Years with Severe Atopic Dermatitis: Results from a Phase III Clinical Trial
Authors (first, second and last of 15)
-
Recommendations for Vaccination in Children with Atopic Dermatitis Treated with Dupilumab: A Consensus Meeting, 2020
Authors (first, second and last of 5)
-
-
Paradoxical Psoriasis in Children Receiving Anti-TNFα Treatment for Inflammatory/autoimmune Disease
Authors (first, second and last of 4)
-
Effect of Dupilumab on Laboratory Parameters in Adolescents with Atopic Dermatitis: Results from a Randomized, Placebo-Controlled, Phase 3 Clinical Trial
Authors (first, second and last of 12)
-
-
Conjunctivitis in Dupilumab Clinical Trials for Adolescents with Atopic Dermatitis or Asthma
Authors (first, second and last of 19)
-
Identifying the Impacts of Acne and the Use of Questionnaires to Detect These Impacts: A Systematic Literature Review
Authors (first, second and last of 13)
-
The Role of Probiotics in the Prevention and Treatment of Atopic Dermatitis in Children: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials
Authors (first, second and last of 7)
-
-
-
Safety, Effectiveness, and Pharmacokinetics of Crisaborole in Infants Aged 3 to < 24 Months with Mild-to-Moderate Atopic Dermatitis: A Phase IV Open-Label Study (CrisADe CARE 1)
Authors (first, second and last of 13)
-
-
-
-
Clinically Meaningful Responses to Dupilumab in Adolescents with Uncontrolled Moderate-to-Severe Atopic Dermatitis: Post-hoc Analyses from a Randomized Clinical Trial
Authors (first, second and last of 19)
-
-
-
Evaluation of Children with Psoriasis from the BiPe Cohort: Are Patients Using Biotherapies in Real Life Eligible for Phase III Clinical Studies?
Authors (first, second and last of 21)
-
-
